Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of complex cause. Gastro-oesophageal reflux (GER) and microaspiration have been proposed as risk factors for the development and progression of IPF, but robust definitive data are few. A recent international guide...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
23 June 2017
|
| In: |
The lancet. Respiratory medicine
Year: 2017, Volume: 5, Issue: 7, Pages: 591-598 |
| ISSN: | 2213-2619 |
| DOI: | 10.1016/S2213-2600(17)30219-9 |
| Online Access: | Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S2213260017302199 Verlag, Volltext: http://dx.doi.org/10.1016/S2213-2600(17)30219-9 
|
| Author Notes: | Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, Jan C Grutters, Claudia Valenzuela, Nesrin Mogulkoc, Fabrizio Luppi, Luca Richeldi, Athol U Wells, Carlo Vancheri, Michael Kreuter, Carlo Albera, Katerina M. Antoniou, Goksel Altinisik, Elisabeth Bendstrup, Benjamin Bondue, Raphael Borie, Kevin K. Brown, Philippe Camus, Diego Castillo, Harold R. Collard, Vincent Cottin, Nunzio Crimi, Giovanni Ferrara, Aryeh Fischer, Jack Gauldie, Thomas Geiser, Andreas Guenther, Nathan Hambly, David M. Hansell, Sergio Harari, Mark G. Jones, Michael Keane, Brett Ley, Toby M. Maher, Maria Molina-Molina, Stefano Palmucci, Venerino Poletti, Antje Prasse, Paola Rottoli, Paolo Spagnolo, Martina Sterclova, Sebastiano Torrisi, Eliza Tsitoura, Martina Vasakova, Simon L. Walsh, Marlies S. Wijsenbeek, Wim A. Wuyts |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581874758 | ||
| 003 | DE-627 | ||
| 005 | 20220815031021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181013s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2213-2600(17)30219-9 |2 doi | |
| 035 | |a (DE-627)1581874758 | ||
| 035 | |a (DE-576)511874758 | ||
| 035 | |a (DE-599)BSZ511874758 | ||
| 035 | |a (OCoLC)1341019924 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Johannson, Kerri A. |e VerfasserIn |0 (DE-588)116896833X |0 (DE-627)1032692839 |0 (DE-576)511874278 |4 aut | |
| 245 | 1 | 0 | |a Antacid therapy in idiopathic pulmonary fibrosis |b more questions than answers? |c Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, Jan C Grutters, Claudia Valenzuela, Nesrin Mogulkoc, Fabrizio Luppi, Luca Richeldi, Athol U Wells, Carlo Vancheri, Michael Kreuter, Carlo Albera, Katerina M. Antoniou, Goksel Altinisik, Elisabeth Bendstrup, Benjamin Bondue, Raphael Borie, Kevin K. Brown, Philippe Camus, Diego Castillo, Harold R. Collard, Vincent Cottin, Nunzio Crimi, Giovanni Ferrara, Aryeh Fischer, Jack Gauldie, Thomas Geiser, Andreas Guenther, Nathan Hambly, David M. Hansell, Sergio Harari, Mark G. Jones, Michael Keane, Brett Ley, Toby M. Maher, Maria Molina-Molina, Stefano Palmucci, Venerino Poletti, Antje Prasse, Paola Rottoli, Paolo Spagnolo, Martina Sterclova, Sebastiano Torrisi, Eliza Tsitoura, Martina Vasakova, Simon L. Walsh, Marlies S. Wijsenbeek, Wim A. Wuyts |
| 264 | 1 | |c 23 June 2017 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.10.2018 | ||
| 520 | |a Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive parenchymal lung disease of complex cause. Gastro-oesophageal reflux (GER) and microaspiration have been proposed as risk factors for the development and progression of IPF, but robust definitive data are few. A recent international guideline conditionally recommended the use of antacid therapy (proton pump inhibitors or histamine-2-receptor antagonists) for patients with IPF, in the absence of oesophageal reflux or symptoms. In this Position Paper, we summarise the literature addressing the association between GER and IPF, and also identify future research priorities that could clarify this issue. We shed light on the process through which the guideline recommendation was achieved and aim to contextualise the recommendation for providers caring for patients with IPF. | ||
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Respiratory medicine |d Oxford : Elsevier, 2013 |g 5(2017), 7, Seite 591-598 |w (DE-627)737292180 |w (DE-600)2704917-6 |w (DE-576)379472759 |x 2213-2619 |7 nnas |a Antacid therapy in idiopathic pulmonary fibrosis more questions than answers? |
| 773 | 1 | 8 | |g volume:5 |g year:2017 |g number:7 |g pages:591-598 |g extent:8 |a Antacid therapy in idiopathic pulmonary fibrosis more questions than answers? |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2213260017302199 |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S2213-2600(17)30219-9 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181013 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1581874758 |e 3028694689 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"more questions than answers?","title":"Antacid therapy in idiopathic pulmonary fibrosis","title_sort":"Antacid therapy in idiopathic pulmonary fibrosis"}],"person":[{"family":"Johannson","given":"Kerri A.","roleDisplay":"VerfasserIn","role":"aut","display":"Johannson, Kerri A."},{"display":"Kreuter, Michael","role":"aut","roleDisplay":"VerfasserIn","given":"Michael","family":"Kreuter"}],"language":["eng"],"name":{"displayForm":["Kerri A Johannson, Irina Strâmbu, Claudia Ravaglia, Jan C Grutters, Claudia Valenzuela, Nesrin Mogulkoc, Fabrizio Luppi, Luca Richeldi, Athol U Wells, Carlo Vancheri, Michael Kreuter, Carlo Albera, Katerina M. Antoniou, Goksel Altinisik, Elisabeth Bendstrup, Benjamin Bondue, Raphael Borie, Kevin K. Brown, Philippe Camus, Diego Castillo, Harold R. Collard, Vincent Cottin, Nunzio Crimi, Giovanni Ferrara, Aryeh Fischer, Jack Gauldie, Thomas Geiser, Andreas Guenther, Nathan Hambly, David M. Hansell, Sergio Harari, Mark G. Jones, Michael Keane, Brett Ley, Toby M. Maher, Maria Molina-Molina, Stefano Palmucci, Venerino Poletti, Antje Prasse, Paola Rottoli, Paolo Spagnolo, Martina Sterclova, Sebastiano Torrisi, Eliza Tsitoura, Martina Vasakova, Simon L. Walsh, Marlies S. Wijsenbeek, Wim A. Wuyts"]},"physDesc":[{"extent":"8 S."}],"id":{"doi":["10.1016/S2213-2600(17)30219-9"],"eki":["1581874758"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"23 June 2017"}],"relHost":[{"title":[{"partname":"Respiratory medicine","title":"The lancet","title_sort":"lancet"}],"language":["eng"],"disp":"Antacid therapy in idiopathic pulmonary fibrosis more questions than answers?The lancet. Respiratory medicine","origin":[{"dateIssuedDisp":"2013-","publisher":"Elsevier","dateIssuedKey":"2013","publisherPlace":"Oxford"}],"recId":"737292180","part":{"issue":"7","volume":"5","year":"2017","extent":"8","pages":"591-598","text":"5(2017), 7, Seite 591-598"},"note":["Gesehen am 01.04.14"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2013 -"],"titleAlt":[{"title":"The lancet <London> / Respiratory medicine"}],"id":{"eki":["737292180"],"zdb":["2704917-6"],"issn":["2213-2619"]}}],"note":["Gesehen am 13.10.2018"],"recId":"1581874758","type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a JOHANNSONKANTACIDTHE2320 | ||